Background: Plac1 is an X-linked gene essential for normal placental development. Plac1 ablation is associated with placentomegaly and intrauterine growth retardation. Additionally, Plac1-null mice exhibit reduced postnatal viability. This study was conducted as part of our ongoing examination of the postnatal phenotype associated with Plac1 ablation.
Methods: Plac1 was deleted in murine embryonic stem cells and bred against a C57BL/6 background. Mutant mice were genotyped using a polymerase chain reaction-based strategy. Embryonic Plac1 expression was assessed by quantitative real-time polymerase chain reaction, in situ hybridization, and β-galactosidase expression.
Results: A total of 20% of the surviving X(m-)Y (knockout) males as well as 10-15% of the X(m-)X females (mutant maternal allele) developed lethal hydrocephalus at 4-8 weeks. By contrast, XX(p-) hets (paternal null allele) did not. Plac1 mRNA expression was detected in the fetal brain that markedly decreased after birth. Plac1 mRNA expression localized to the hindbrain and lateral ventricles of wild-type embryos. Additionally, Plac1 expression was observed throughout the fetus including the fetal lungs, kidney, intestine, liver, and heart. Embryonic Plac1 expression was paternally imprinted with partial escape of the paternal allele from complete inactivation. The Plac1 protein localized to the apical surface of the epithelial cells lining the developing airways of the lung and proximal renal tubules, consistent with its localization in the differentiated syncytiotrophoblast.
Conclusion: Plac1 is expressed in the brain in a developmentally regulated manner and its absence is linked to increased risk for hydrocephalus. It is also widely expressed in fetal tissues expanding the existing paradigm to include direct tissue-specific roles during development.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/bdra.23171 | DOI Listing |
Cell Signal
January 2025
Department of Urology, the First Affiliated Hospital of Soochow University, Suzhou 215000, China. Electronic address:
Clear cell renal cell carcinoma (ccRCC) is a common clinical tumor of the urinary system. The lack of effective diagnostic and treatment options poses a serious challenge to clinical treatment. Therefore, identifying effective molecular targets has become one of the potential means to treat this disease.
View Article and Find Full Text PDFLife Sci
December 2024
Department of Gynecology and Obstetrics, Shanghai Fifth People's Hospital, Fudan University, Shanghai 200240, PR China; Central Laboratory, Shanghai Fifth People's Hospital, Fudan University, Shanghai 200240, PR China. Electronic address:
Aims: This study investigated the molecular mechanisms of placenta-specific protein 1 (PLAC1) in cervical cancer (CCa), aiming to elucidate its role in tumorigenesis through in vitro and in vivo experiments.
Materials And Methods: CCa cell lines with overexpressed or silenced PLAC1 were established to evaluate its impact on cell cycle, apoptosis and the expression of key proteins in the PLAC1/mTOR/HIF-1α/Snail signaling pathways. Functional assays were conducted to assess the influence of the PLAC1/mTOR/HIF-1α/Snail regulatory pathway on cell proliferation, migration and invasion.
Mol Hum Reprod
November 2024
Department of Physiology and Aging, College of Medicine, University of Florida, Gainesville, FL, USA.
Currently, there are no placenta-targeted treatments to alter the in utero environment for administration to pregnant women who receive a diagnosis of fetal growth restriction (FGR). Water-soluble polymers have a distinguished record of clinical relevance outside of pregnancy. We have demonstrated the effective delivery of polymer-based nanoparticles containing a non-viral human insulin-like growth factor 1 (IGF1) transgene to correct placental insufficiency in small animal models of FGR.
View Article and Find Full Text PDFPeerJ
November 2024
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Background: Colorectal cancer is a common condition with an uncommon burden of disease, heterogeneity in manifestation, and no definitive treatment in the advanced stages. Renewed efforts to unravel the genetic drivers of colorectal cancer progression are paramount. Early-stage detection contributes to the success of cancer therapy and increases the likelihood of a favorable prognosis.
View Article and Find Full Text PDFPlacenta
September 2024
Department of Physiology and Aging, College of Medicine, University of Florida, Gainesville, FL, USA; Center for Research in Perinatal Outcomes, College of Medicine, University of Florida, Gainesville, FL, USA. Electronic address:
Nanoparticles offer promise as a mechanism to non-invasively deliver targeted placental therapeutics. Our previous studies utilizing intraplacental administration demonstrate efficient nanoparticle uptake into placental trophoblast cells and overexpression of human IGF1 (hIGF1). Nanoparticle-mediated placental overexpression of hIGF1 in small animal models of placental insufficiency and fetal growth restriction improved nutrient transport and restored fetal growth.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!